First Mercantile Trust’s Heron Therapeutics HRTX Stock Holding History

First Mercantile Trust’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$54K	Sell	5,019 -281	-5%	-$3.42K	0.01%	768
2021 Q2	$82K	Sell	5,300 -582	-10%	-$9.26K	0.01%	737
2021 Q1	$95K	Sell	5,882 -690	-10%	-$12.3K	0.01%	692
2020 Q4	$139K	Sell	6,572 -451	-6%	-$7.84K	0.02%	578
2020 Q3	$120K	Buy	7,023 +1,101	+19%	+$17.2K	0.01%	616
2020 Q2	$87K	Buy	+5,922	New	+$97.3K	0.01%	713

Other funds holding HRTX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

First Mercantile Trust's HRTX Position: Q3 2021 in Review

First Mercantile Trust reduced its Heron Therapeutics (HRTX) stake by 5.3% in Q3 2021, selling an estimated $3.42K and leaving 5,019 shares worth $54K. The position accounts for 0.01% of the portfolio, ranked #768.

First Mercantile Trust first reported a position in HRTX in Q2 2020 and has held it in 6 quarters since. The position peaked at $139K in Q4 2020. 197 funds tracked by Wall St. Rank hold HRTX as of Q3 2021.

First Mercantile Trust held 5,019 shares of Heron Therapeutics worth $54K as of Q3 2021.
First Mercantile Trust sold 281 Heron Therapeutics shares in Q3 2021, an estimated $3.42K.
Heron Therapeutics made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #768 holding.
First Mercantile Trust first reported a position in Heron Therapeutics in Q2 2020 and has held it in 6 quarters since.
First Mercantile Trust's Heron Therapeutics position peaked at $139K in Q4 2020.
197 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.